| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.FORSCIINT.2014.04.017 |
| P698 | PubMed publication ID | 24810679 |
| P2093 | author name string | Julie Evans | |
| Simon Elliott | |||
| P921 | main subject | 1-(3-trifluoromethylphenyl)piperazine | Q419405 |
| P304 | page(s) | 55-60 | |
| P577 | publication date | 2014-04-16 | |
| P1433 | published in | Forensic Science International | Q15766274 |
| P1476 | title | A 3-year review of new psychoactive substances in casework | |
| P478 | volume | 243 |
| Q49602724 | "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA. |
| Q92575706 | 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors |
| Q35917086 | AH-7921: the list of new psychoactive opioids is expanded |
| Q41908015 | Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition. |
| Q50858829 | Analysis of selected designer benzodiazepines by ultra high performance liquid chromatography with high-resolution time-of-flight mass spectrometry and the estimation of their partition coefficients by micellar electrokinetic chromatography. |
| Q39834312 | Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives |
| Q40694962 | Analytical characterization of bioactive N-benzyl-substituted phenethylamines and 5-methoxytryptamines |
| Q48246805 | Assessing the toxicological significance of new psychoactive substances in fatalities. |
| Q36619477 | Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014. |
| Q50217113 | Contribution of serotonin and dopamine to changes in core body temperature and locomotor activity in rats following repeated administration of mephedrone. |
| Q49628077 | Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine |
| Q53479625 | Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC-MS/MS. |
| Q97522652 | Determination of 37 fentanyl analogues and novel synthetic opioids in hair by UHPLC-MS/MS and its application to authentic cases |
| Q34538013 | Determination of MDPBP in postmortem blood samples by gas chromatography coupled with mass spectrometry |
| Q35181582 | Discriminative and locomotor effects of five synthetic cathinones in rats and mice |
| Q53087323 | Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine. |
| Q41531681 | Driving under the influence of synthetic phenethylamines: a case series |
| Q39714625 | Editor's Highlight: Characterization of Hepatotoxicity Mechanisms Triggered by Designer Cathinone Drugs (β-Keto Amphetamines). |
| Q48212400 | Effect of the combination of mephedrone plus ethanol on serotonin and dopamine release in the nucleus accumbens and medial prefrontal cortex of awake rats. |
| Q39761680 | First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry |
| Q34463746 | First reported fatalities associated with the 'research chemical' 2-methoxydiphenidine. |
| Q88578159 | Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone |
| Q89736093 | Hazard Characterization of Synthetic Cathinones Using Viability, Monoamine Reuptake, and Neuronal Activity Assays |
| Q40506281 | Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana). |
| Q55059127 | In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol. |
| Q34504512 | In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant |
| Q86043162 | Indirect chiral separation of new recreational drugs by gas chromatography-mass spectrometry using trifluoroacetyl-L-prolyl chloride as chiral derivatization reagent |
| Q48211628 | Intended and unintended use of cathinone mixtures |
| Q96020143 | Intoxication cases associated with the novel designer drug 3',4'-Methylenedioxy-α-pyrrolidinohexanophenone (MDPHP) and studies on its human metabolism by high-resolution mass spectrometry |
| Q52313567 | Intoxication caused by new psychostimulants: analytical methods to disclose acute and chronic use of benzofurans and ethylphenidate. |
| Q26799231 | Legal highs: staying on top of the flood of novel psychoactive substances |
| Q47647717 | Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats |
| Q42395888 | Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents |
| Q89736148 | Mephedrone and Alcohol Interactions in Humans |
| Q28276182 | NPS: Medical Consequences Associated with Their Intake |
| Q34667835 | Novel psychoactive substances of interest for psychiatry. |
| Q30251771 | Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. |
| Q34466872 | Pharmacological profile of novel psychoactive benzofurans |
| Q51004232 | Rapid analysis of drugs of abuse and their metabolites in human urine using dilute and shoot liquid chromatography-tandem mass spectrometry. |
| Q38894030 | Reporting Two Fatalities Associated with the Use of 4-Methylethcathinone (4-MEC) and a Review of the Literature. |
| Q30148688 | Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review |
| Q28607852 | Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting |
| Q90115152 | Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions |
| Q53505020 | Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry. |
| Q33467435 | Simultaneous identification and quantification of new psychoactive substances in blood by GC-APCI-QTOFMS coupled to nitrogen chemiluminescence detection without authentic reference standards |
| Q50300878 | Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release |
| Q94558018 | Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants |
| Q47567624 | Synthetic Aminoindanes: A Summary of Existing Knowledge. |
| Q89835205 | Synthetic Cathinones Induce Cell Death in Dopaminergic SH-SY5Y Cells via Stimulating Mitochondrial Dysfunction |
| Q39845731 | Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator |
| Q58602767 | Synthetic cathinone adulteration of illegal drugs |
| Q47736105 | The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online population |
| Q41126358 | The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland |
| Q38669049 | The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland |
| Q57805603 | The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates |
| Q38980529 | Two Cases of Non-fatal Intoxication with a Novel Street Hallucinogen: 3-Methoxy-Phencyclidine. |
Search more.